Propiedad y actividad de insiders de Amylyx Pharmaceuticals, Inc. (AMLX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $32.63 |
| Capitalización | $3.6B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-10 | Bedrosian Camille L | S-Sale | 7,947 | $256K |
| 2026-09-10 | Bedrosian Camille L | S-Sale | 2,081 | $69K |
| 2026-09-10 | FRATES JAMES M | S-Sale | 9,768 | $315K |
| 2026-09-10 | FRATES JAMES M | S-Sale | 1,042 | $35K |
| 2026-09-10 | Mazzariello Gina | S-Sale | 9,525 | $309K |
| 2026-09-10 | Mazzariello Gina | S-Sale | 11 | $367 |
| 2026-09-10 | Klee Justin B. | S-Sale | 29,025 | $933K |
| 2026-09-10 | Klee Justin B. | S-Sale | 1,439 | $48K |
| 2026-09-10 | Cohen Joshua B | S-Sale | 29,545 | $950K |
| 2026-09-10 | Cohen Joshua B | S-Sale | 919 | $30K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.1M | $12.9M | $50.2M | $62.5M | $170.2M | $77.4M | $226.7M |
| Inversiones a Corto | 0 | 0 | $45.9M | $284.4M | $201.2M | $99.1M | $90.3M |
| Cuentas por Cobrar | 0 | 0 | 0 | $15.3M | $40.0M | $447000 | $88000 |
| Inventario | 0 | 0 | 0 | $9.8M | $38.3M | 0 | 0 |
| Activos Corrientes | $3.2M | $13.6M | $105.0M | $382.1M | $464.7M | $189.4M | $323.7M |
| Inmovilizado Material | 0 | $151000 | $474000 | $8.1M | $6.4M | $2.7M | $5.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $3.2M | $14.1M | $105.6M | $391.5M | $517.5M | $193.6M | $332.6M |
| Cuentas por Pagar | $2.2M | $3.6M | $4.4M | $6.3M | $22.1M | $2.9M | $3.5M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $4.5M | $7.3M | $17.4M | $46.6M | $82.0M | $28.4M | $22.7M |
| Deuda a Largo | $14.9M | $1.4M | 0 | 0 | 0 | 0 | $4.7M |
| Pasivos Totales | $28.6M | $80.8M | $256.8M | $50.8M | $84.0M | $28.9M | $27.4M |
| Reservas | -$25.6M | -$67.9M | -$155.8M | -$354.2M | -$304.9M | -$606.7M | -$751.4M |
| Patrimonio Neto | -$25.4M | -$66.7M | -$151.2M | $340.6M | $433.4M | $164.8M | $305.3M |
| Deuda Total | $14.9M | $1.4M | 0 | $6.3M | $4.2M | $2.0M | $6.0M |
| Deuda Neta | $11.9M | -$11.5M | -$96.1M | -$340.7M | -$367.1M | -$174.5M | -$311.0M |
| Capital Circulante | -$1.3M | $6.3M | $87.6M | $335.5M | $382.6M | $161.0M | $301.0M |
Empresas relacionadas: ATAI · CVAC · IMTX · INBX · NKTR · ORIC · PGEN
Explorar sector: Healthcare · Biotechnology
Más secciones de AMLX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones